Midazolam In Sodium Chloride Injection, Solution
Product Images NDC 65219-650
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Midazolam In Sodium Chloride (NDC 65219-650). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fresenius Kabi Logo (Mid0i 0000 02)
Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Bag Label)
This text pertains to a High Alert Medication - Midazolam - in 0.9% Sodium Chloride Injection. It contains important information such as the dosage (50 mg per 50 mL), usage instructions (intravenous use only), and storage conditions (20° to 25°C). It also emphasizes not to dilute or add supplementary medications. Users should check for leaks before administration, and discard any leaked containers to avoid sterility issues. Additionally, the mention of a single-dose container highlights the importance of discarding any unused portion.*
Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Overpouch Label)
This text provides information about the medication "Uderole" in 0.9% Sodium Chloride Injection. It includes details about the dosage, instructions for use, warnings regarding dilution and series connections, storage conditions, manufacturer details, and the unique identification number. The medication is indicated for intravenous use only and comes in a single-dose container. Additionally, it is important to check for leaks and discard if found to ensure sterility. For full prescribing information, one should refer to the package insert.*
Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Carton Label)
Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Bag Label)
This text provides information about a high alert medication called Midazolam in 0.9% Sodium Chloride Injection. The medication comes in a 100 mg per 100 mL concentration, with instructions for intravenous use only. It is emphasized not to dilute the medication, add supplementary medication, or use in series connections. The packaging is a single-dose container, and any unused portion should be discarded. The manufacturer is Fresenius Kabi, and the product is made in India. Storage instructions include keeping it within a temperature range of 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The text also includes precautions against freezing and guidance for checking container leaks for sterility.*
Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Overpouch Label)
This text provides important information about a high alert medication for intravenous use. It includes instructions on how to open the container, dosage recommendations, storage conditions, and manufacturer details. The medication is in a single-dose container and should not be diluted or used in series connections. Leaks should be checked for and if found, the container should be discarded. The unused portion should also be discarded. The text advises against adding supplementary medication and presents storage temperature limits to ensure stability.*
Package Label (PRINCIPAL DISPLAY – Midazolam in 0.9% Sodium Chloride Injection Carton Label)
This text is a pharmaceutical label providing information about a medication in the form of 10 single-dose bags to be used intravenously. The medication contains 100 mg per 100 mL (1 mg per mL) and is not to be diluted. The label includes instructions not to add supplementary medication and not to use in series connections for intravenous administration. It also mentions that if any leaks are found, the sterility may be impacted. The storage temperature is recommended between 20° to 25°C. The label further states that any unused portion should be discarded and refers to the package insert or prescribing information for the recommended dosage.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.